Elixinol Wellness Limited ELLXF
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -368.90K | -367.50K | -789.90K | -787.40K | -990.70K |
| Total Depreciation and Amortization | 128.80K | 128.30K | 117.50K | 117.10K | 163.70K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -5.20K | -5.10K | -175.90K | -175.30K | 384.00K |
| Change in Net Operating Assets | -- | -- | 247.40K | 246.70K | -- |
| Cash from Operations | -245.20K | -244.30K | -600.90K | -599.00K | -443.00K |
| Capital Expenditure | -7.20K | -7.20K | -17.10K | -17.00K | -4.20K |
| Sale of Property, Plant, and Equipment | 16.20K | 16.10K | -- | -- | -- |
| Cash Acquisitions | -- | -- | -38.40K | -38.30K | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -4.50K | -4.50K | -5.60K | -5.60K | -5.40K |
| Cash from Investing | 4.50K | 4.50K | -61.00K | -60.80K | -9.60K |
| Total Debt Issued | 198.50K | 198.50K | 104.00K | 104.00K | 699.00K |
| Total Debt Repaid | -45.50K | -45.50K | -105.00K | -105.00K | -47.50K |
| Issuance of Common Stock | -- | -- | 1.27M | 1.27M | 75.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -163.50K | -163.50K | -6.00K |
| Cash from Financing | 105.40K | 105.00K | 724.90K | 722.60K | 461.60K |
| Foreign Exchange rate Adjustments | -5.50K | -5.50K | 41.40K | 41.20K | -6.10K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -140.90K | -140.30K | 104.40K | 104.00K | 2.90K |